Literature DB >> 8158043

Varicella-zoster virus (VZV) reactivation is related to the low response of VZV-specific immunity after chickenpox in infancy.

K Terada1, S Kawano, K Yoshihiro, T Morita.   

Abstract

To clarify the cause of herpes zoster in immunocompetent children, specific humoral and cellular immunity was determined using an ELISA and a lymphoproliferative assay, respectively, in infants < 1 year of age and children > or = 1 year of age who had chickenpox. Thirteen (59.1%) of 22 infants, 17 (81.0%) of 21 children > or = 1 year of age (P < .02), and 13 (86.7%) of 15 children > or = 2 years of age (P < .001) had positive varicella-zoster virus (VZV)-specific cellular immunity. VZV-specific antibodies in infants were significantly lower than those in children > or = 1 year old (P < .01) and > or = 2 years old (P < .001). The possibility of subclinical reactivation was demonstrated by an increase in the specific cellular or humoral immunity (or both) in all of 6 infants who had negative specific cellular immunity. The low response of specific immunity and the immunologic evidence of reactivation in infants after chickenpox provide a possible explanation for the finding that chickenpox in infancy is a risk factor for herpes zoster.

Entities:  

Mesh:

Year:  1994        PMID: 8158043     DOI: 10.1093/infdis/169.3.650

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Varicella: to vaccinate or not to vaccinate?

Authors:  A Gershon
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

2.  Alteration of T cells and natural killer cells during chickenpox in infancy.

Authors:  K Terada; S Kawano; Y Yagi; Y Shimada; N Kataoka
Journal:  J Clin Immunol       Date:  1996-01       Impact factor: 8.317

3.  Robust gene expression changes in the ganglia following subclinical reactivation in rhesus macaques infected with simian varicella virus.

Authors:  Nicole Arnold; Christine Meyer; Flora Engelmann; Ilhem Messaoudi
Journal:  J Neurovirol       Date:  2017-03-20       Impact factor: 2.643

Review 4.  Taking stock of infections and antibiotic resistance in the elderly and long-term care facilities: A survey of existing and upcoming challenges.

Authors:  S Augustine; R A Bonomo
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-09-09

5.  Risk factors for breakthrough varicella in healthy children.

Authors:  Y J Lim; F T Chew; A Y Tan; B W Lee
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

6.  Reactivation of chickenpox contracted in infancy.

Authors:  K Terada; S Kawano; Y Hiraga; T Morita
Journal:  Arch Dis Child       Date:  1995-08       Impact factor: 3.791

7.  Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.

Authors:  Myron J Levin; Jeffrey P Anderson; George R Seage; Paige L Williams
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

8.  Herpes zoster and meningitis in an immunocompetent child: a case report.

Authors:  Ryu Yasuda; Kisei Minami; Akira Ogawa; Hideshi Okada; Runa Terakawa; Yumi Koike; Shinji Ogura; Kouichi Takeuchi; Tsukasa Higuchi
Journal:  J Med Case Rep       Date:  2019-06-15

Review 9.  Current In Vivo Models of Varicella-Zoster Virus Neurotropism.

Authors:  Ravi Mahalingam; Anne Gershon; Michael Gershon; Jeffrey I Cohen; Ann Arvin; Leigh Zerboni; Hua Zhu; Wayne Gray; Ilhem Messaoudi; Vicki Traina-Dorge
Journal:  Viruses       Date:  2019-05-31       Impact factor: 5.048

10.  Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster.

Authors:  Benson Ogunjimi; Lander Willem; Philippe Beutels; Niel Hens
Journal:  Elife       Date:  2015-07-11       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.